UPPthera Inc is a pharmaceutical venture company founded in 2018 in South Korea. Specializing in new drug development, the company utilizes cutting-edge 'protein degradation technology' to address unmet medical needs in the pharmaceutical industry. In its latest funding round on 19th May 2022, UPPthera secured a significant KRW28.00B in Series B investment. The round saw participation from prominent investors such as IBK Capital, IMM Investment, Meritz Securities, Paratus Investment Inc., Albatross Investment, SBI Investment Korea, and In Light Ventures.
UPPTHERA, Inc.
Pharmaceutical company (New drug development)
Founded 2018
Korea South
19 employees
Series B
Total: $28.00B
Pharmaceutical
Korea South
19 employees
Series B
Total: $28.00B
Pharmaceutical
General Information
Company Name
UPPTHERA, Inc.
Founded Year
2018
Location
Korea South
Korea South
Employees
19
Industries
Pharmaceutical
Funding Stage
Series B
BounceWatch is an independent company data service, not affiliated with UPPTHERA, Inc.. To contact UPPTHERA, Inc., visit uppthera.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Korea South Market
Pharmaceutical
About UPPTHERA, Inc.
Taxonomy: pharmaceutical company, drug development, protein degradation technology, biopharmaceuticals, therapeutics, clinical research
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | KRW28.00B | 7 |
|
19 May 2022 |
| Series A | Undisclosed | 3 |
|
22 Jul 2020 |
UPPTHERA, Inc. Alternatives & Competitors
View All Alternatives
UPPTHERA, Inc. vs
Captor Therapeutics SA
Poland
Captor Therapeutics aims to treat cancer, infections, and diseases by targeting the difficult-to-dru...
IPO
79 employees
Biopharma, Biotechnology
UPPTHERA, Inc. vs
Autotelic Bio Inc.
Korea South
RNA Therapeutics New Drug Development Company
Series B
15 employees
Biotechnology, Pharmaceutical
UPPTHERA, Inc. vs
C4 Therapeutics, Inc.
United States
Clinical-stage biotech company transforming how disease is treated through targeted protein degradat...
IPO
111 employees
Biotechnology, Health Care
FAQ About UPPTHERA, Inc.
Pharmaceutical company (New drug development)
UPPTHERA, Inc. was founded in 2018.
UPPTHERA, Inc. is headquartered in Korea South.
UPPTHERA, Inc. operates in Pharmaceutical. Its work centres on pharmaceutical company, drug development, protein degradation technology and biopharmaceuticals.
UPPTHERA, Inc. has approximately 19 employees.
UPPTHERA, Inc. has completed 2 funding rounds, raising a total of $28.00B. The latest funding stage is Series B.
Top alternatives and competitors to UPPTHERA, Inc. include Captor Therapeutics SA, Autotelic Bio Inc., C4 Therapeutics, Inc., Kangpu Biopharmaceuticals, Ltd., X-37. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
UPPTHERA, Inc. and Captor Therapeutics SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for UPPTHERA, Inc., https://bouncewatch.com/company/uppthera, updated 11 November 2024. When citing, please name BounceWatch and link this page.
